Search
SOLACI Congress
Farmacotherapy

Therapeutic strategies for the control of dyslipemia

solaci
solaci
115
0

Ada-Cuevas
Ada Cuevas
2011-08-03

Previous article
Cierre percutáneo de ductus arterioso permeable en lactantes
Next article
Antiplatelet therapy advance in ACS and PCI
solaci
solaci

More articles by this author

Antiplatelet therapy advance in ACS and PCI

solaci - 0
Jorge Belardi 2011-08-05

Interruption of antiplatelet therapy for non-cardiac surgery

solaci - 0
Ajay Kirtane 2011-08-03

Protección gástrica en pacientes sometidos a angioplastia coronaria

solaci - 0
Gastón Dussaillant 2011-08-03

Rol actual de los nuevos antiplaquetarios en el síndrome coronario agudo

solaci - 0
Ramón Corbalan 2011-08-03

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Farmacotherapy

Antiplatelet therapy advance in ACS and PCI

Jorge Belardi 2011-08-05
solaci -
SOLACI Sessionsspot_img

Recent Articles

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

Dr. Omar Tupayachi - 0
The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...

TAVR in Small Annuli: What Valve Should We Use?

Dr. Carlos Fava - 0
One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Dr. Andrés Rodríguez - 0
Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

Dr. Omar Tupayachi - 0
The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...

TAVR in Small Annuli: What Valve Should We Use?

Dr. Carlos Fava - 0
One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Dr. Andrés Rodríguez - 0
Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

Institutional News

April 9 – How to Apply for the SOLACI Research Grant 2025? Virtual Zoom Event

solaci - 0
The Latin American Society of Interventional Cardiology invites you to a new virtual event hosted by the SOLACI Research Department, aimed at clarifying doubts,...

Watch our event on Evidence and Controversies of Renal Denervation in 2025

solaci - 0
You can now watch our event, held in collaboration with Medtronic, titled "Evidence and Controversies of Renal Denervation in 2025." The event featured international experts...

March 26 – SOLACI Webinar: Evidence and Controversies in Renal Denervation in 2025

solaci - 0
The Latin American Society of Interventional Cardiology invites you to a new virtual event supported by Medtronic. On this occasion, we will hold a 60-minute...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy